Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial

NACompletedINTERVENTIONAL
Enrollment

755

Participants

Timeline

Start Date

March 21, 2018

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Atrial Fibrillation and Flutter
Interventions
DEVICE

R Test 4 External Loop Recorder

The R-Test 4 is an externally worn, re-usable, battery-powered, lightweight ECG monitor, which records events triggered by cardiac arrhythmias. It is worn for 7 days. Cardiac monitoring is triggered by tachycardia or detection of irregular pulses or patient may trigger recording, if the participant experience symptoms (e.g. palpitations). The patient wears 2 chest leads (on one, the R-Test device is attached, weight 42g). The R-Test 4 is CE marked, and uses an FDA-approved algorithm for automatic detection of atrial fibrillation, and permits 5 minutes of pre-event recording and 5 minutes of post-event recording.

Trial Locations (1)

H91 YR71

HRB Clinical Research Facility Galway, Galway

All Listed Sponsors
collaborator

Health Research Board, Ireland

OTHER

lead

National University of Ireland, Galway, Ireland

OTHER

NCT03911986 - Risk-Based Screening for the Evaluation of Atrial Fibrillation Trial | Biotech Hunter | Biotech Hunter